Testimony | In Person
Event Title
Combatting The Youth Vaping Epidemic By Enhancing Enforcement Against Illegal E-Cigarettes
June 12, 2024
- Testimony of
-
Brian King
Introduction
Chair Durbin, Ranking Member Graham, and Members of the Committee, thank you for the opportunity to testify before you to discuss the Food and Drug Administration’s (FDA or the Agency) efforts, in collaboration with our federal partners, to address the sale of unauthorized e-cigarettes. FDA’s Center for Tobacco Products (CTP)’s mission is to protect the public health of the U.S. population from tobacco-related death and disease by comprehensively regulating the manufacture, distribution, and marketing of tobacco products, including through enforcement actions; educating the public, especially youth, about the dangers of using tobacco products; and promoting and supporting strategies that ensure an equitable chance at living a healthier life for everyone. FDA shares the goals and the urgency of keeping all tobacco products out of the hands of our youth and preventing the sale of unauthorized e-cigarettes. An “all of government” approach is critical to achieving these goals. FDA has actively been working, including with our colleagues across the federal government, to meet those shared goals.